Search Within

GME, Medicine

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (228)
  2. Journal Article (177)
  3. Research Letter (10)
  4. Review (4)
  5. Correspondence (2)
  6. Editorial (2)
Groups
  1. Epidemiology and Biostatistics (423)
  2. Graduate Medical Education (423)
  3. Department of Medicine (399)
  4. Biostatistics Service (340)
  5. Hematology-Oncology Fellows (270)
  6. Hematologic Malignancies, Division of (256)

More Groups

People
  1. Gunjan Shah (95)
  2. Michael Scordo (94)
  3. Andriy Derkach (89)
  4. Sergio Giralt (85)
  5. Kylee Maclachlan (77)
  6. Alexander Lesokhin (71)

More People

Years
  1. 2025 (30)
  2. 2024 (105)
  3. 2023 (136)
  4. 2022 (95)
  5. 2021 (30)
  6. 2020 (17)

More Years

Publications
  1. Journal of Clinical Oncology (95)
  2. Blood (74)
  3. Clinical Lymphoma, Myeloma and Leukemia (27)
  4. Clinical Cancer Research (17)
  5. Annals of Oncology (12)
  6. Blood Advances (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (102)
  2. American Society of Hematology (86)
  3. Elsevier Inc. (54)
  4. Nature Publishing Group (38)
  5. American Association for Cancer Research (32)
  6. Oxford University Press (24)

More Publishers

Results (423)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development
    Meeting Abstract

    Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer
    Meeting Abstract

    Lattanzi, M.; Solovyov, A.; Lihm, J.; Quinlan, C.; Whiting, K.; Li, H.; Al-Ahmadie, H. A.; Teo, M. Y.; Aggen, D. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Oral minoxidil for the treatment of late alopecia in cancer survivors
    Meeting Abstract

    Kuo, A. M. S.; Reingold, R. E.; Ketosugbo, K.; Pan, A.; Dusza, S. W.; Kraehenbuehl, L.; Gajria, D.; Lake, D. E.; Bromberg, J.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Chromosomal instability (CIN) in circulating tumor cells (CTC) predicts for taxane sensitivity in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Keegan, N. M.; Arfe, A.; Barnett, E.; Cohn, E. D.; Zhao, J.; Carbone, E.; Zanone, M.; Anderson, A.; Wenstrup, R.; Scher, H. I.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Cowzer, D.; White, J. B.; Chen, P. J.; Kim, T. H.; Khalil, D.; El Dika, I. H.; Chou, J. F.; Yaqubie, A.; Light, J. S.; Shia, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma: Final results
    Meeting Abstract

    Cowzer, D.; Wu, A. J. C.; Sihag, S.; Walch, H. S.; Park, B. J.; Jones, D. R.; Gu, P.; Maron, S. B.; Sugarman, R.; Chalasani, S. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical efficacy of daratumumab (DARA)-based second line therapy after DARAcontaining and DARA-free induction therapies in multiple myeloma: A single center experience
    Meeting Abstract

    Ciardiello, A.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Lu, S. X.; Patel, D.; Maclachlan, K.; Lahoud, O. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Identification of pretreatment genomic biomarkers and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
    Meeting Abstract

    Choudhury, N. J.; Marra, A.; Yang, S. R.; Falcon, C. J.; Heller, G.; Kris, M. G.; Reis-Filho, J. S.; Riely, G. J.; Yu, H. A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Single agent PD-1 blockade as curative-intent treatment in mismatch repair deficient locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Lumish, M. A.; Sinopoli, J. C.; Weiss, J. A.; Shia, J.; Stadler, Z. K.; Yaeger, R.; Smith, J. J.; Saltz, L. B.; El Dika, I. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save